Clinical Proteomic Research for the Brain

Massachusetts General Hospital750 enrolled

Overview

The study of plasma and urine proteomic profiles in patients with ischemic brain injury is important to better understanding of the mechanisms by which thrombolytic agents or other therapy affects clinical outcomes. The purpose of this study is to study the proteomic profile of patients with ischemic brain injury and compare it to control subjects without ischemic brain injury, subjects with other chronic neurologic diseases or systemic vascular diseases, and pre- and post- therapy which may be associated with, or predictive of, therapeutic outcome. The investigators hypothesize that there is a unique set of proteins expressed in serum and urine in patients with ischemic brain injury that may provide a more complete understanding of ischemic brain injury pathophysiology. Ultimately, this study may provide information of direct relevance to the medical care of a large proportion of patients with ischemic brain injury and other neurologic diseases in the future. And proteomic proteomic profile may provide important information about the roles of specific biomarkers. Perhaps the prevention of ischemic injury related complications.

Study Type

OBSERVATIONAL

Enrollment

750

Conditions

Ischemic Brain Injury Stroke Healthy Individual Patent Foramen Ovale (PFO)Neurovascular Injury

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Case Inclusion and Exclusion Criteria: Inclusion Criteria: 1. Ischemic brain injury within 12 hours of symptom onset; 2. Including primary ischemic brain injury from embolism or arterial occlusion or secondary due to increased ICP after trauma, subarachnoid hemorrhage. Exclusion Criteria: 1. Patients who are hemodynamically unstable for venipunctures; 2. Anemic patients (hemoglobin \< 11); 3. Children; 4. Pregnant women. Controls Inclusion and Exclusion Criteria: Inclusion Criteria: 1. Healthy adults without any neurologic or systemic disease; 2. Inpatient or outpatient adults with a chronic stroke (greater than 3 months) or chronic neurologic disease such as neurodegenerative disease, movement disorder, demyelinating disease; 3. Inpatient or outpatient adults with systemic vascular disease. Exclusion Criteria: 1. Patients who are hemodynamically unstable for venipunctures; 2. Anemic patients (hemoglobin \< 11); 3. Children; 4. Pregnant women.

Clinical Proteomic Research for the Brain

Overview

Conditions

Eligibility

Locations (1)

Outcomes

Primary Outcomes

Central Contacts